Kimia Biosciences Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 263659,
    "name": "Kimia Bioscien.",
    "stock_name": "Kimia Bioscien.",
    "full_name": "Kimia Biosciences Ltd",
    "name_url": "stocks-analysis/kimia-bioscien",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.00",
    "chg": 1.98,
    "chgp": "6.6%",
    "dir": 1,
    "prev_price": "30.02",
    "mcapval": "144.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530313,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE285U01025",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.37 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/kimia-bioscien-263659-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.26.09 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs2609-amidst-continued-downtrend-3741786",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscience_priceRelatedfactors_3741786.png",
        "date": "2025-12-02 12:42:30",
        "description": "Kimia Biosciences touched a fresh 52-week low of Rs.26.09 today, marking a significant decline amid a sustained downward trend. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices over the past year."
      },
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs272-amidst-continued-downtrend-3738369",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscience_priceRelatedfactors_3738369.png",
        "date": "2025-12-01 11:12:33",
        "description": "Kimia Biosciences has reached a new 52-week low of Rs.27.2, marking a significant decline in its stock price amid a sustained downward trend over recent days. The pharmaceutical and biotechnology company’s shares have underperformed relative to its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics."
      },
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs272-amidst-continued-downtrend-3738368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KimiaBioscience_priceRelatedfactors_3738368.png",
        "date": "2025-12-01 11:12:33",
        "description": "Kimia Biosciences has reached a new 52-week low of Rs.27.2 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical and biotechnology company’s shares have underperformed both its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics."
      },
      {
        "title": "Kimia Biosciences Falls to 52-Week Low of Rs.28.4 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-stock-falls-to-52-week-low-of-rs284-3735819",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KimiaBioscience_priceRelatedfactors_3735819.png",
        "date": "2025-11-28 15:07:24",
        "description": "Kimia Biosciences has reached a new 52-week low of Rs.28.4 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Why is Kimia Bioscien. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kimia-bioscien-fallingrising-3721872",
        "imagepath": "",
        "date": "2025-11-22 00:31:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Stock Performance Against Benchmarks</strong></p>\n<p>Kimia Biosciences has underperformed markedly compared to the broader market indices over multiple time horizons. Over the past week, the stock declined by 7.59%, while the Sensex gained 0.79%. This negative trend extends over longer periods, with the stock falling 8.83% in the last month and a steep 30.59% over the past year, contrasting sharply with the Sensex’s 10.47% gain during the same period. Even over three and five years, the stock has lagged significantly, registering losses of 19.88% and 26.81% respectively, while the Sensex surged by 39.39% and 94.23%. These figures underscore persistent underperformance and investor caution surrounding the company.</p>\n<p><strong>Intraday Volatility and Trading Patterns</strong></p>\n<p>On 21-N..."
      },
      {
        "title": "Kimia Biosciences Q2 FY26: Margin Compression Overshadows Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/kimia-biosciences-q2-fy26-margin-compression-overshadows-revenue-growth-3718748",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KimiaBioscience_quaterlyResult_3718748.png",
        "date": "2025-11-18 16:37:16",
        "description": "Kimia Biosciences Ltd., a Gurgaon-based pharmaceutical company specialising in bulk drug manufacturing, reported net profit of ₹1.02 crores for Q2 FY26, marking a sequential increase of 70.00% from ₹0.60 crores in Q1 FY26. However, year-on-year comparison reveals a concerning decline of 36.65% from ₹1.61 crores in Q2 FY25. The company's stock, trading at ₹34.00 with a modest market capitalisation of ₹159 crores, has struggled significantly, declining 27.66% over the past year whilst the broader Sensex gained 9.48%."
      },
      {
        "title": "Kimia Biosciences Financial Trend Shifts to Flat Amid Mixed Quarterly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-q3-2025-financial-trend-shifts-to-flat-amid-margin-pressures-3712223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KimiaBioscience_fintrenddot_3712223.png",
        "date": "2025-11-18 16:00:29",
        "description": "Kimia Biosciences, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable adjustment in its financial trend parameter, moving from a negative to a flat evaluation in the quarter ending September 2025. This shift reflects a stabilisation in key financial metrics despite ongoing challenges in profitability and margin performance."
      },
      {
        "title": "Is Kimia Bioscien. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kimia-bioscien-overvalued-or-undervalued-3709667",
        "imagepath": "",
        "date": "2025-11-18 08:18:31",
        "description": "As of 17 November 2025, the valuation grade for Kimia Bioscien. has moved from fair to attractive, indicating a positive shift in its market perception. The company is currently considered undervalued, especially when compared to its peers in the pharmaceuticals and biotechnology sector. Key ratios include a PE Ratio of 19.11, an EV to EBITDA of 10.35, and an impressive ROE of 82.13%. \n\nIn comparison to its peers, Kimia Bioscien. stands out with a significantly lower PEG Ratio of 0.11, while Sun Pharma. is deemed expensive with a PE Ratio of 36.69 and an EV to EBITDA of 24.22. Other peers like Divi's Lab and Torrent Pharma are also classified as very expensive, with PE Ratios of 69.78 and 59.48, respectively. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -27.62% compared to the Sensex's 8.72%, the valuation metrics suggest that Kimia Bioscien. presents a compellin..."
      },
      {
        "title": "How has been the historical performance of Kimia Bioscien.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-kimia-bioscien-3708531",
        "imagepath": "",
        "date": "2025-11-17 22:53:55",
        "description": "Answer:\nThe historical performance of Kimia Bioscien shows a fluctuating trend in net sales and profitability over the years, with a notable recovery in the latest fiscal year.\n\nBreakdown:\nKimia Bioscien's net sales peaked at 132.71 Cr in Mar'21 but have since declined, reaching 118.92 Cr in Mar'25. The total operating income followed a similar pattern, with a high of 132.71 Cr in Mar'21 and a decrease to 118.92 Cr in Mar'25. Raw material costs increased to 74.55 Cr in Mar'25 from 67.36 Cr in Mar'24, while total expenditure decreased to 98.67 Cr in Mar'25 from 105.36 Cr in Mar'24. Operating profit (PBDIT) showed a significant recovery, rising to 21.57 Cr in Mar'25 from a loss of 0.48 Cr in Mar'24. Profit before tax also improved to 13.63 Cr in Mar'25, compared to a loss of 7.18 Cr in Mar'24, leading to a profit after tax of 9.61 Cr in Mar'25, a recovery from a loss of 5.31 Cr in the previous year. The compa..."
      }
    ],
    "total": 171,
    "sid": "263659",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/kimia-biosciences-263659"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)",
      "datetime": "02-Feb-2026",
      "details": "Intimation of Resignation of Chief Financial Officer(CFO) key Managerial Personnel under Regulation 30 of SEBI(listing Obligations and Disclosure Requirements)Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "10-Jan-2026",
      "details": "Certificate pursuant to Regulation 74(5) of the SEBI(Depositories and participants)Regulations2018",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "07-Jan-2026",
      "details": "Intimation under regulation 30 of SEBI(LODR) regulations2015-appointment of chief financial officer(CFO) Key Managerial Personnel",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kimia Biosciences Falls to 52-Week Low of Rs.26.09 Amidst Continued Downtrend

2025-12-02 12:42:30

Kimia Biosciences touched a fresh 52-week low of Rs.26.09 today, marking a significant decline amid a sustained downward trend. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices over the past year.

Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend

2025-12-01 11:12:33

Kimia Biosciences has reached a new 52-week low of Rs.27.2, marking a significant decline in its stock price amid a sustained downward trend over recent days. The pharmaceutical and biotechnology company’s shares have underperformed relative to its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics.

Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend

2025-12-01 11:12:33

Kimia Biosciences has reached a new 52-week low of Rs.27.2 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical and biotechnology company’s shares have underperformed both its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics.

Kimia Biosciences Falls to 52-Week Low of Rs.28.4 Amidst Continued Downtrend

2025-11-28 15:07:24

Kimia Biosciences has reached a new 52-week low of Rs.28.4 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices.

Why is Kimia Bioscien. falling/rising?

2025-11-22 00:31:22

Stock Performance Against Benchmarks Kimia Biosciences has underperformed markedly compared to the broader market indices over multiple time horizons. Over the past week, the stock declined by 7.59%, while the Sensex gained 0.79%. This negative trend extends over longer periods, with the stock falling 8.83% in the last month and a steep 30.59% over the past year, contrasting sharply with the Sensex’s 10.47% gain during the same period. Even over three and five years, the stock has lagged significantly, registering losses of 19.88% and 26.81% respectively, while the Sensex surged by 39.39% and 94.23%. These figures underscore persistent underperformance and investor caution surrounding the company. Intraday Volatility and Trading Patterns On 21-N...

Kimia Biosciences Q2 FY26: Margin Compression Overshadows Revenue Growth

2025-11-18 16:37:16

Kimia Biosciences Ltd., a Gurgaon-based pharmaceutical company specialising in bulk drug manufacturing, reported net profit of ₹1.02 crores for Q2 FY26, marking a sequential increase of 70.00% from ₹0.60 crores in Q1 FY26. However, year-on-year comparison reveals a concerning decline of 36.65% from ₹1.61 crores in Q2 FY25. The company's stock, trading at ₹34.00 with a modest market capitalisation of ₹159 crores, has struggled significantly, declining 27.66% over the past year whilst the broader Sensex gained 9.48%.

Kimia Biosciences Financial Trend Shifts to Flat Amid Mixed Quarterly Performance

2025-11-18 16:00:29

Kimia Biosciences, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable adjustment in its financial trend parameter, moving from a negative to a flat evaluation in the quarter ending September 2025. This shift reflects a stabilisation in key financial metrics despite ongoing challenges in profitability and margin performance.

Is Kimia Bioscien. overvalued or undervalued?

2025-11-18 08:18:31

As of 17 November 2025, the valuation grade for Kimia Bioscien. has moved from fair to attractive, indicating a positive shift in its market perception. The company is currently considered undervalued, especially when compared to its peers in the pharmaceuticals and biotechnology sector. Key ratios include a PE Ratio of 19.11, an EV to EBITDA of 10.35, and an impressive ROE of 82.13%. In comparison to its peers, Kimia Bioscien. stands out with a significantly lower PEG Ratio of 0.11, while Sun Pharma. is deemed expensive with a PE Ratio of 36.69 and an EV to EBITDA of 24.22. Other peers like Divi's Lab and Torrent Pharma are also classified as very expensive, with PE Ratios of 69.78 and 59.48, respectively. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -27.62% compared to the Sensex's 8.72%, the valuation metrics suggest that Kimia Bioscien. presents a compellin...

How has been the historical performance of Kimia Bioscien.?

2025-11-17 22:53:55

Answer: The historical performance of Kimia Bioscien shows a fluctuating trend in net sales and profitability over the years, with a notable recovery in the latest fiscal year. Breakdown: Kimia Bioscien's net sales peaked at 132.71 Cr in Mar'21 but have since declined, reaching 118.92 Cr in Mar'25. The total operating income followed a similar pattern, with a high of 132.71 Cr in Mar'21 and a decrease to 118.92 Cr in Mar'25. Raw material costs increased to 74.55 Cr in Mar'25 from 67.36 Cr in Mar'24, while total expenditure decreased to 98.67 Cr in Mar'25 from 105.36 Cr in Mar'24. Operating profit (PBDIT) showed a significant recovery, rising to 21.57 Cr in Mar'25 from a loss of 0.48 Cr in Mar'24. Profit before tax also improved to 13.63 Cr in Mar'25, compared to a loss of 7.18 Cr in Mar'24, leading to a profit after tax of 9.61 Cr in Mar'25, a recovery from a loss of 5.31 Cr in the previous year. The compa...

View All News